Your browser doesn't support javascript.
loading
Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment.
Garbe, Claus; Keim, Ulrike; Amaral, Teresa; Berking, Carola; Eigentler, Thomas K; Flatz, Lukas; Gesierich, Anja; Leiter, Ulrike; Stadler, Rudolf; Sunderkötter, Cord; Tüting, Thomas; Utikal, Jochen; Wollina, Uwe; Zimmer, Lisa; Zouboulis, Christos C; Ascierto, Paolo A; Eggermont, Alexander M M; Grob, Jean-Jacques; Hauschild, Axel; Sekulovic, Lidija Kandolf; Long, Georgina V; Luke, Jason J; Michielin, Olivier; Peris, Ketty; Schadendorf, Dirk; Kirkwood, John M; Lorigan, Paul C.
Afiliación
  • Garbe C; Department of Dermatology, Center for Dermatooncology, Eberhard Karls University of Tübingen, Tübingen, Germany.
  • Keim U; Department of Dermatology, Center for Dermatooncology, Eberhard Karls University of Tübingen, Tübingen, Germany.
  • Amaral T; Department of Dermatology, Center for Dermatooncology, Eberhard Karls University of Tübingen, Tübingen, Germany.
  • Berking C; Department of Dermatology, University Hospital Erlangen, Erlangen, Germany.
  • Eigentler TK; Department of Dermatology, Skin Cancer Center, Charité Berlin, Berlin, Germany.
  • Flatz L; Department of Dermatology, Center for Dermatooncology, Eberhard Karls University of Tübingen, Tübingen, Germany.
  • Gesierich A; Department of Dermatology, University Hospital Wuerzburg, Wuerzburg, Germany.
  • Leiter U; Department of Dermatology, Center for Dermatooncology, Eberhard Karls University of Tübingen, Tübingen, Germany.
  • Stadler R; Department of Dermatology, Johannes Wesling Hospital Minden, Ruhr-University of Bochum, Minden, Germany.
  • Sunderkötter C; Department of Dermatology and Venereology, University Hospital Halle, Halle, Germany.
  • Tüting T; Department of Dermatology, University Hospital Magdeburg, Magdeburg, Germany.
  • Utikal J; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Wollina U; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
  • Zimmer L; Department of Dermatology and Allergology, Municipal Hospital of Dresden, Dresden, Germany.
  • Zouboulis CC; Department of Dermatology, University Hospital Essen, Essen, Germany.
  • Ascierto PA; German Cancer Consortium, Heidelberg Partner Site Essen, Essen, Germany.
  • Eggermont AMM; Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.
  • Grob JJ; Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.
  • Hauschild A; Princess Máxima Center, Utrecht, the Netherlands.
  • Sekulovic LK; University Medical Center Utrecht, Utrecht, the Netherlands.
  • Long GV; Comprehensive Cancer Center Munich, Munich, Germany.
  • Luke JJ; Dermatology and Skin Cancer Department, APHM Timone, Aix-Marseille University, Marseille, France.
  • Michielin O; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.
  • Peris K; Department of Dermatology, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia.
  • Schadendorf D; Melanoma Institute Australia, The University of Sydney, Mater Hospital, Sydney, Australia.
  • Kirkwood JM; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Lorigan PC; Cancer Immunotherapeutic Center of UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA.
J Clin Oncol ; 40(32): 3741-3749, 2022 11 10.
Article en En | MEDLINE | ID: mdl-35709414
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Alemania